Amicus Therapeutics

Acquired

Home - Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases

Public · Cranbury, United States · Founded 2002 · $86.0M raised

Employees
501–1000
Founded
2002
Business Model
B2B
Total Funding
$86.0M
Last Round
Venture RoundJan 2006
Rounds
4
Type
Public
Acquired by
BioMarin Pharmaceutical Inc.Apr 2026 · $4.8B

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Oral pharmacological chaperone protein therapies to address diseases that result from protein misfolding

Summary

Amicus Therapeutics is a Biotech company based in Cranbury, United States, founded in 2002. It has raised $86.0M in total across 4 rounds, most recently a Venture Round in Jan 2006. Investors include Quaker BioVentures, Canaan Partners and Blackstone.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionDec 2025

Sign up to see all 6 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amicus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/amicus-therapeutics"><img src="https://indexed.vc/api/badge/company/amicus-therapeutics" alt="Amicus Therapeutics on Indexed.vc" width="260" height="76" /></a>